SJRNF yields 1818.18% · PFE yields 6.13%● Live data
📍 SJRNF pulled ahead of the other in Year 1
Combined, SJRNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SJRNF + PFE for your $10,000?
ArcWest Exploration Inc. engages in the exploration of mineral properties in Canada. It primarily explores for copper and gold deposits. The company holds 100% interests in the Todd Creek property located in northeast of Stewart; the Oweegee Dome property that covers an area of 31,077 hectares located in east of Tudor Gold's Treaty Creek; the Oxide Peak property, which covers an area of 8,438 hectares located in the Toodoggone District; the Teeta Creek property located in northern Vancouver Island, British Columbia; and the Northern Vancouver Island property that covers an area of 6,884 hectares located in northern Vancouver. It also has interests in the Rip property, which covers an area of 7,811 hectares situated in south of Houston; Sparrowhawk project that covers an area of 9,913 hectares located in southeast of the Morrison Cu deposit; and the Eagle property covering an area of 2,530 hectares located in in northern Vancouver Island, British Columbia. The company was formerly known as Sojourn Exploration Inc. and changed its name to ArcWest Exploration Inc. in February 2019. ArcWest Exploration Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Full SJRNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.